S&P 500, Nasdaq Close Lower as AI Euphoria Encounters a 5% Reality Check – Sept. 14, 2026 -( $AMWL $CRWD $EXOD $MODD $OKTA $PANW $SER $SMWB $VIX Rise! )

U.S. stocks finished lower Monday, September 14, 2026, as investor appetite for risk weakened under the combined weight of a selloff in AI-linked semiconductor shares, elevated crude oil prices, and a sharp rise in Treasury yields ahead of this week’s Federal Reserve decision. The S&P 500 fell 0.48%, the Dow Jones Industrial Average lost 0.29%, and the Nasdaq Composite declined 0.56%, according to the closing market data supplied.

Closing market performance

Index / Asset	Closing Level	Daily Change
S&P 500	7,619.98	-37.00 (-0.48%)
Dow Jones Industrial Average	52,421.20	-152.09 (-0.29%)
Nasdaq Composite	26,186.41	-146.62 (-0.56%)
Russell 2000	2,892.24	-11.71 (-0.40%)
CBOE Volatility Index (VIX)	17.13	+1.29 (+8.15%)
Gold	$4,326.60	-$82.30 (-1.87%)
Bitcoin	$79,296.99	+$1,973.68 (+2.55%)
WTI Crude Oil, October contract	$101.74	+$1.69 (+1.69%)

The action was broadly defensive rather than indiscriminately risk-off. All four major U.S. equity benchmarks closed in the red, while the VIX climbed more than 8%, signaling an increase in demand for portfolio protection. Small-cap stocks, represented by the Russell 2000, also moved lower as higher financing costs remained a challenge for businesses that are generally more sensitive to credit conditions.

What moved markets

The primary equity-market pressure came from renewed questions around the pace and economics of the artificial-intelligence buildout. Weekend calls from leaders at private AI firms Anthropic and OpenAI for greater caution in advancing frontier models raised concern that a slower pace of capability development could eventually affect the capital-expenditure outlook underpinning the AI trade. That concern landed directly on semiconductors and infrastructure suppliers. CNBC reported notable intraday weakness in NVIDIA (NVDA), Broadcom (AVGO), Advanced Micro Devices (AMD), Intel (INTC), and Marvell Technology (MRVL), while Yahoo Finance also highlighted declines across Micron Technology (MU), Super Micro Computer (SMCI), CoreWeave (CRWV), and SanDisk (SNDK). The market’s reaction reflects a repricing of expectations, not necessarily a rejection of AI’s long-term importance, but a reassessment of how quickly AI-related revenue, data-center spending, and model deployment may scale. Cybersecurity was a relative area of interest as investors considered whether heightened AI-related risks could reinforce enterprise security spending. Yahoo Finance cited early strength in Okta (OKTA), CrowdStrike Holdings (CRWD), and Palo Alto Networks (PANW). that rose north of double digits today,

Macro report: higher yields meet higher oil

Monday’s market weakness was not solely a technology story. The macro backdrop became materially more difficult as the benchmark 10-year U.S. Treasury yield briefly reached 5%, its highest intraday level since October 2023.. The 30-year yield was also elevated, near the mid-5% range. Higher long-term interest rates matter because they increase the discount rate investors apply to future corporate earnings, typically a headwind for long-duration growth stocks, including many technology and AI beneficiaries. They also feed through to the real economy via mortgage rates, automobile financing, corporate borrowing costs, and consumer credit. At the same time, energy markets remained unsettled. WTI crude settled at $101.74 per barrel, up 1.69%, while gold fell 1.87% to $4,326.60. The supplied close followed reports that Saudi Arabia had shut a key pipeline bypassing the Strait of Hormuz, amplifying concerns about supply disruption and the inflationary consequences of sustained high oil prices.bAugust consumer prices reportedly rose 3.4% year over year, while average hourly earnings rose 3.1%. That combination renews concerns that household purchasing power could be under pressure if inflation remains elevated.

Federal Reserve focus

Markets now turn to the Federal Reserve’s policy decision later this week on Wednesday. Many services reported that futures-market pricing had shifted sharply toward a possible 25-basis-point rate increase following recent inflation data, though former Federal Reserve officials and some policymakers have suggested the outcome may be more finely balanced than market-implied probabilities indicate. For msny, the key issue will extend beyond the rate decision itself:

• Whether the Federal Reserve views the recent inflation acceleration as temporary or persistent.
• Whether elevated energy prices change the Committee’s near-term inflation outlook.
• Whether policymakers acknowledge that long-term Treasury yields near 5% are already tightening financial conditions.
• Whether the Fed’s language signals a single precautionary move or the beginning of a more sustained tightening phase.

A rate increase or strongly hawkish guidance could pressure valuation-sensitive equities further. Conversely, an unchanged policy rate accompanied by a credible commitment to inflation control could provide some short-term relief, though elevated oil prices and long-duration yields would remain important constraints.

A takeaway

Monday’s close showed a market confronting a three-part test: a potential moderation in AI enthusiasm, an energy-driven inflation risk, and an interest-rate environment that is becoming more restrictive. The decline in the S&P 500, Dow, Nasdaq, and Russell 2000, alongside the VIX increase, suggests many folks are reducing exposure ahead of an important Federal Reserve week rather than making a wholesale exit from equities. The clearest near-term gauges to watch are the 10-year Treasury yield, crude-oil prices, the Fed’s policy statement, and whether AI-linked leaders such as NVIDIA (NVDA), Broadcom (AVGO), AMD (AMD), Intel (INTC), and Marvell Technology (MRVL) can stabilize after the latest repricing. A sustained move in oil above $100 per barrel or a durable 10-year yield above 5% would likely keep pressure on equity valuations, particularly within expensive growth and semiconductor segments.

VP Watchlist Updates

Amwell® (NYSE: AMWL)

Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, closed at $13.87, +6.69% after nearly hitting the 52-week high off $14.19. AMWK is up 108.89% over the last year.

AMWL announced (Sept 8) announced the Department of Veterans Affairs (VA) has declared its intent for the Company to deploy its virtual health platform within the VA enterprise and help power the modernization of the VA’s digital health infrastructure. The VA anticipates the Amwell platform will support a broad range of clinical services, enhance care coordination, and improve access for our Veterans across the VA enterprise. The Letter of Intent follows a comprehensive evaluation process by the VA, in which it determined that Amwell’s virtual health platform aligns with the Department’s strategic objectives to expand access to high-quality, secure, and reliable virtual care services for Veterans nationwide through the VA’s current electronic health record modernization efforts. Specifically, the capabilities Amwell demonstrated in scalable video consultations, interoperability, cybersecurity compliance, and support for integrated care delivery were significant factors in this determination.

Amwell® has received Frost & Sullivan’s 2026 United States Technology Innovation Leadership Recognition in the Technology-Enabled Care Platforms Industry. The recognition validates Amwell’s ability to address healthcare fragmentation through a unified platform that orchestrates consumer experiences, clinician workflows, care programs, and partner solutions.

The Company also reiterated recently its objective to achieve positive cash flow from operations in the fourth quarter of 2026.

Serina Theraeuptics (NYSE : SER)

Serina Theraeuptics (NYSE : SER, $2.45, +10.36%) is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s POZ PlatformTM provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Serina is headquartered in Huntsville, Alabama on the campus of the HudsonAlpha Institute of Biotechnology.

SER announced (Sept. 9) that the independent Safety Monitoring Committee (SMC) has completed its blinded review of Cohort 1 of the ongoing Phase 1b registrational study of SER-252 in patients with advanced Parkinson’s disease and recommended that the study advance to Cohort 2. Cohort 1 evaluated the lowest dose level in the single-ascending-dose portion of the study. In addition to supporting continued dose escalation, blinded Cohort 1 observations showed a pharmacokinetic profile consistent with the sustained apomorphine exposure SER-252 is designed to provide and included sustained periods of improvement in motor function in individual patients on exploratory clinical measures.

Hudson Pacific Properties (NYSE: HPP)

Hudson Pacific Properties (NYSE: HPP, $11.74) is a real estate investment trust serving dynamic tech and media tenants in global epicenters for these synergistic, converging and secular growth industries. Hudson Pacific’s unique and high-barrier tech and media focus leverages a full-service, end-to-end value creation platform forged through deep strategic relationships and niche expertise across identifying, acquiring, transforming and developing properties into world-class amenitized, collaborative and sustainable office and studio space. HPP turned in a quarter ( Aug. 5) that suggests the office malaise is not over, but it may finally be meeting resistance. Revenue came in above Wall Street’s expectations, occupancy moved higher for a fourth straight quarter, and management raised full-year guidance, a combination that does not make for a triumphant victory lap, but it does make for a more credible turnaround narrative. Learn more.

Eupraxia Pharmaceuticals Inc. (EPRX)

Eupraxia Pharmaceuticals Inc. (EPRX, $8.07), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, announced (Aug. 13) positive results from a new analysis of the RESOLVE study examining the effect of EP-104GI on symptom severity, including for the first time an analysis of the effect of EP-104GI on odynophagia (pain when swallowing). This is important because odynophagia scoring is a component of Dysphagia Symptom Questionnaire (DSQ), a commonly used patient reported outcome used in pivotal clinical trials in EoE patients.

Modular Medical, Inc. (NASDAQ: MODD)

Modular Medical, Inc. (NASDAQ: MODD, $2.58, +1.57%), a commercial-stage medical device company preparing for the commercial launch of its next-generation Pivot™ tubeless patch pump, announced (September 4) that it has secured a contract with a national U.S. pharmacy benefit manager (PBM) in the United States. Pursuant to the contract, the Company’s Pivot insulin delivery system is now available through the national PBM. The Company believes the engagement with this national PBM represents a significant step forward in broadening patient access to the Company’s Pivot tubeless patch pump and will further validate the Pivot pump as an accessible therapeutic option for people living with diabetes.

MODD announced (September 3) that the U.S. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system, further expanding the system’s functionality and providing users with greater flexibility and customization options in bolus dosing, an enhanced user-interface (UI), and other software upgrades.

MODD CEO, Jeb Besser, co-hosted a Tribe Public’s CEO Presentation and Q&A Webinar Event titled “The Road To Revenue: Modular Medical’s Strategy For Launching Pivot,” that was held Friday, September 4, 2026 (8:30am PT / 11:30 am ET). You may watch the event video below now if you missed it below now.

MODD announced (Aug. 3) plans to initiate the first phase of commercialization of its Pivot tubeless patch pump across five strategically selected U.S. markets beginning in October 2026. The initial rollout will include Atlanta, Cincinnati/Lexington, Dallas, Houston, and Philadelphia, representing a foundational step in the Company’s capital efficient commercialization strategy with its mission to expand access to simplified insulin delivery solutions for all people living with diabetes.

MODD recently (July 22) announced the formation of its Pivot Innovation Council, a cross-functional group of leading clinicians and healthcare experts established to help guide the company’s clinical and commercial strategy. Diabetes care expert Robert Gabbay, MD, PhD, FACP was appointed as chair of the Pivot Innovation Council. The council will provide insights on target patient populations, support optimization of clinical workflows, inform evidence-generation initiatives, and help refine the Pivot product roadmap and go-to-market approach, as the Company continues to scale its differentiated offering.

Modular released findings (July 15) from an independent market research study demonstrating positive receptivity to its FDA-cleared Pivot™ tubeless patch pump due to its differentiated design, streamlined user experience, and potential for reimbursement through the pharmacy channel.

Similarweb Ltd. (NYSE: SMWB)

Similarweb explores the many ways AI, apps, and other transformational forces are changing online shopping in its State of Ecommerce 2026 report, published on Sept 10. They reported that despite increasing more than 200% over the past year, direct referrals from dedicated AI platforms don’t produce a large volume of traffic to ecommerce marketplaces and online stores. In other words, compared with search, AI conversations don’t result in as much immediate click-through traffic. However, AI buying recommendations exert an outsize influence on purchases – in some cases, giving the recommended brand a 2-to-1 advantage over its competitors. Consumers are also making ChatGPT, Gemini, and other conversational AI tools a routine part of the buying process. However, that doesn’t mean they are abandoning search, 89% of the time, consumers who use AI in their shopping research also use search. “Consumers are not switching tools, they are stacking them,” said Daniel Reid, Principal Insight Analyst, Consumer Goods & Retail at Similarweb and the lead author of the report. “People are using AI to explore and narrow options while still turning to Search to move toward a decision. The most complex journeys, the ones that use both, convert the best. Retailers and brands who figure out how to master these new paths to product discovery stand to benefit.”

Similarweb Ltd. (NYSE: SMWB) and NIQ (NYSE: NIQ) have recently announced their planned Agentic Commerce Measurement solution aims to connect AI-based product discovery with consumer intent, traffic, conversion and verified sales outcomes. The first version is expected in the fourth quarter of 2026, initially across selected categories and markets. For many, the strategic appeal is simple: as AI becomes an increasingly consequential front door to commerce, the value may accrue not only to the companies building AI assistants, but also to the data-and-measurement providers that tell enterprises whether all that artificial intelligence is generating actual revenue, or merely very articulate window-shopping.

SMWB also recently delivered the sort of second-quarter report investors tend to enjoy: revenue and profitability exceeded guidance, full-year expectations moved higher, and AI demand translated into contracts rather than merely conference-call poetry. SMWB closed at $8.61, +6.69% Learn More.

LG Display Co., Ltd. (LPL)

LG Display Co., Ltd. (NYSE: LPL, $3.13) has spent the last few years doing something many hardware companies talk about but few execute well: turning a technology pivot into a full‑blown business transformation that everyday investors can actually follow. Instead of chasing commoditized LCD TV panels in a race to the bottom, LPL is leaning into Gaming OLED, CES‑worthy innovation, and premium automotive displays – and the press trail tells a surprisingly investor‑friendly story.

Yatsen Group (NYSE: YSG)

Yatsen Group (NYSE: YSG, $2.58), a leading China-based beauty group, delivered the sort of quarter that can make a turnaround investor sit up straighter: reported revenue grew, its strategically important skincare operation accelerated sharply, and the company is increasingly built around clinical and premium brands rather than a pure color-cosmetics play. The results are not yet a victory lap, losses widened and third-quarter guidance is cautious, but YSG’s transformation is beginning to look less like a cosmetic touch-up and more like a genuine renovation.

YSG announced (July 8) a landmark collaboration to bring its flagship brand, Perfect Diary, to Sephora in China. This partnership integrates Yatsen’s rigorous scientific infrastructure with the world’s leading prestige beauty retailer, marking a significant milestone in Yatsen’s continuing evolution into a global beauty technology powerhouse.

Doximity, Inc. (NYSE:DOCS)

Doximity (NYSE: DOCS, $26.39, +3.17%) is the leading digital platform for U.S. medical professionals. The company’s network members include more than 85% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay current on medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits.

Doximity, Inc. (NYSE: DOCS) announced (Aug. 6) results of its fiscal 2027 first quarter ended June 30, 2026. Jeff Tangney, co-founder and CEO of Doximity, “We’re proud that our clinical AI assistant, Doximity Ask, was the top-performing U.S.-based model in the NOHARM benchmark while we delivered another quarter of record engagement. In Q1 we had accelerated revenue growth along with workflow active prescriber growth of more than 30% year-over-year and AI Search query growth of over 25% quarter-over-quarter.”

Fiscal 2027 First Quarter Financial Highlights

All comparisons, unless otherwise noted, are to the three months ended June 30, 2025.

• Revenue: Revenue of $156.6 million, versus $145.9 million, an increase of 7% year-over-year.
• Net income and non-GAAP net income: Net income of $24.3 million, versus $53.3 million, representing a margin of 15.5%, versus 36.5%. Non-GAAP net income of $55.0 million, versus $71.9 million, representing a margin of 35.1%, versus 49.2%.
• Adjusted EBITDA: Adjusted EBITDA of $74.8 million, versus $79.8 million, a decrease of 6% year-over-year, representing adjusted EBITDA margins of 47.7%, versus 54.7%.
• Diluted net income per share and non-GAAP diluted net income per share: Diluted net income per share was $0.13, versus $0.27, while non-GAAP diluted net income per share was $0.29, versus $0.36.
• Operating cash flow and free cash flow: Operating cash flow of $42.0 million, versus $62.1 million, a decrease of 32% year-over-year, and free cash flow of $39.6 million, versus $60.1 million, a decrease of 34% year-over-year.

Financial Outlook

Doximity is providing guidance for its fiscal second quarter ending September 30, 2026 as follows:

• Revenue between $170 million and $171 million.
• Adjusted EBITDA between $80.5 million and $81.5 million.

Doximity is updating guidance for its fiscal year ending March 31, 2027 as follows:

• Revenue between $671 million and $681 million.
• Adjusted EBITDA between $309 million and $329 million.

Sable Offshore Corp. (SOC)

Sable Offshore Corp. (NYSE: SOC, $4.82) has moved from the awkward “pre-revenue restoration project” phase into something much more recognizable to Wall Street: a company selling meaningful volumes of oil, generating operating cash flow, and building momentum into a potentially larger 2027 earnings base. The second-quarter report on Monday was not a polished victory lap—midstream bottlenecks and one-time costs made sure of that—but it offered something potentially more valuable: proof that the Santa Ynez Unit restart is translating into barrels, revenue, and operational traction. Learn more.

T1 Energy Inc. (NYSE: TE)

T1 Energy Inc. (NYSE: TE, $4.37) offers a different type of growth story: one rooted in domestic production, trade-policy tailwinds and execution on solar manufacturing capacity. T1 announced (Aug. 27) that local officials in Mo i Rana, Norway, have rezoned a portion of the company’s Giga Arctic campus, allowing for the development of a data center. T1 is pursuing multiple pathways to monetize this brownfield facility as part of a value optimization initiative.

T1 recently reported second-quarter net sales of $250.1 million, produced 935 megawatts of solar modules at its G1_Dallas facility and generated adjusted EBITDA of $10.7 million. The company also monetized $39.1 million of 2025 Section 45X tax credits and ended the quarter with $156.4 million in cash, cash equivalents and restricted cash, including $79.1 million unrestricted. The headline loss should not be ignored: T1 reported a $36.9 million net loss from continuing operations, while its adjusted EBITDA benefited from $24.4 million in tariff refunds recognized in cost of sales. Yet the more interesting investor question is whether the company is creating a viable U.S. solar-manufacturing platform at a time when supply-chain security and domestic energy capacity carry unusually high strategic value. The company expects its first solar cells from a planned 2.1-gigawatt manufacturing facility in the first quarter of 2027. With 3 gigawatts of firm contracts, a 641-megawatt offtake agreement with Clearway and 2026 output expected toward the upper end of its 3.1-to-4.2-gigawatt range, T1’s story is increasingly about turning production capacity into contracted revenue. For investors, TE is less a conventional earnings multiple story than an execution-and-optionality story. If domestic solar demand remains durable and manufacturing milestones stay on schedule, the market may ultimately value the company less like a troubled commodity producer and more like a strategically positioned industrial platform.

Nvidia (NVDA, $210.96, -3.36%)

NVDA announced plans (Sept. 3) to acquire open-AI platform Hugging Face for approximately $13 billion, with closing expected in 2027. The move reinforces NVIDIA’s effort to deepen its position across AI infrastructure, development tools, and the open-source AI ecosystem. Learn More.

Nvidia once again delivered (Wed., August 26) results that made Wall Street’s estimates look rather conservative. After the bell on Wednesday, NVIDIA, for its fiscal second quarter, the AI-chip leader reported adjusted earnings of $2.22 per share, ahead of the $2.10 consensus forecast, while revenue reached $96.22 billion, comfortably above expectations of $92.17 billion. The performance underscores Nvidia’s central role in the global AI buildout, where demand for its computing hardware continues to turn ambitious data-center plans into exceptionally large purchase orders. In short: the company remains one of the market’s preferred ways to bet on artificial intelligence, and, judging by the numbers, the machines are still very much hungry.

Exodus Movement, Inc. (EXOD, $6.33, +5.32%)

Exodus Movement, Inc. (NYSE American: EXOD) offers investors an increasingly unusual combination: a publicly traded software company positioned at the intersection of crypto adoption, self-custody, consumer finance and digital-asset infrastructure. In a sector accustomed to grand promises and occasionally vanishing balance sheets, Exodus sells a more practical proposition—help users securely manage, swap, stake and spend digital assets without handing over the keys. That model is gaining relevance as cryptocurrency moves beyond the speculative trading screen and toward everyday financial utility. Exodus is not trying to become a bank in a hoodie; it is building the user-friendly front door to a self-custodial digital-asset economy.

The Sources

Sources

1. CNBC Stock Market Today: Live Updates
2. Yahoo Finance — Stock Market Today: Dow, S&P 500 and Nasdaq Fall as Anthropic’s AI Warning Spooks Tech Traders, 10-Year Yield Hits 5%
3. Reuters Fed’s Table Is Set for a Rate Hike, a First Under Warsh  Federal Reserve policy expectations, elevated inflation, oil above $100 per barrel, and the 10-year Treasury yield’s move to 5%.
4. Yahoo Finance Five Things to Watch in Markets This Week: AI, Fed, BOJ, BOE and Oil  AI policy concerns, central-bank decisions and developments affecting the Strait of Hormuz.
5. Associated Press via Local 10 AI Stocks Drop, but the Rest of Wall Street Holds Steadier After Oil Prices Give Back an Early Jump  AI-sector weakness, the 10-year Treasury yield’s brief move to 5%, and oil-market developments.
6. Bloomberg Stocks Fall on AI Fears as 10-Year Yield Hits 5%  Chipmaker pressure, AI-development concerns, higher crude prices and their effect on Treasury yields.
7. Saxo Bank Oil Up, Chips Down, Fed Ahead: September 14, 2026  August U.S. inflation data, rate-hike probabilities and Treasury-market conditions.
8. U.S. News & World Report Fed Meets Amid Uncertainty Over Oil, AI and Inflation  The macroeconomic backdrop surrounding the Federal Reserve meeting, energy inflation and AI-related market concerns.
9. Yahoo Finance S&P 500, Nasdaq Fall on AI Slowdown Fears, Oil Price Surge  Semiconductor declines, AI-industry slowdown concerns, rising oil prices and broad equity-market pressure.

Disclosure: This article is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any security. Market data are subject to revision, and investors should conduct independent due diligence before making investment decisions. Investments may involve substantial risk, including the potential loss of the entire investment. Investors should conduct independent due diligence and consider their individual objectives and risk tolerance. See The Complete Disclosure via this link & at the top of the page.